BIRD-C (Biotech Innovation Research Development and Consulting) is a SME specialized in vaccine development for prevention of human and veterinary infectious diseases.  

BIRD-C is pioneer in application of cutting-edge Bacterial Ghost (BG) platform technology.

The company offers scale-able solutions for delivery of biologically active substances (e.g. chemotherapeutic drugs), vaccines and adjuvants against emerging and existing infectious and life threatening diseases with an innovative focus on Bacterial Ghosts Cancer Immunotherapy (BGCI).